DAVINA LITTLE: Open Payments
NPI 1902412117 · AUGUSTA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,541 in 76 payments from 15 companies in 2025. Trend: 2023 $1,059 · 2024 $961 · 2025 $1,541
Food & beverage: $1,541
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $386 |
| Bayer Healthcare Pharmaceuticals Inc. | 12 | $213 |
| ABBVIE INC. | 10 | $161 |
| Vanda Pharmaceuticals Inc. | 4 | $159 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $157 |
| Novo Nordisk Inc | 15 | $148 |
| Otsuka America Pharmaceutical, Inc. | 4 | $89 |
| Lilly USA, LLC | 4 | $80 |
| Axsome Therapeutics, Inc. | 1 | $29 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $29 |
Products named: AIRSUPRA, Kerendia, FANAPT, CAPLYTA, Wegovy, REXULTI, BREZTRI, MOUNJARO.
Industry payments across KS — which companies pay providers there.
